Systematic review compares different anticoagulants for cerebral venous thrombosis, indicating their ranking for effectiveness and safety.
This study aims to compare different direct oral anticoagulants (DOACs) with vitamin K antagonists (VKAs) for managing cerebral venous thrombosis (CVT) and rank them accordingly.
No takes yet. Share an insight, caveat, or question.
Waseem et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: